20 Jul 2022 --- A team of researchers in the US is set to investigate the effect of benfotiamine – a synthetic version of thiamine vitamin B1 – as a metabolic treatment approach to Alzheimer’s disease, after landing a US$45 million grant from the National Institute of Health and National Institute on Aging.
